Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Great article and mention of ACAN. Check it out. $ACAN
https://www.dailymarijuanaobserver.com/single-post/2017/04/27/IIPR-The-Cannabis-REIT-is-Crushing-its-Benchmark
ACAN is trading nicely and if it goes above $5.50 it will be an all time high and be picked up on the breakout boards.
Lots of good things going on with the cannabis industry generally and Massachusetts and ACAN in particular. $ACAN
$ACAN
This interview is with Matt Kearns the managing partner of Greenwave Advisors a leading cannabis industry research firm in NY.
He mentions Americann (ACAN) as one of the cannabis stocks to watch and mentions their big Massachusetts production project. $ACAN
http://m.benzinga.com/article/9306494
Here Are The 5 Stocks Added To The U.S. Marijuana Index
Americann (ACAN) was one of five new stocks just added to the US Marijuana Index.
This story below in Forbes provides the details. $ACAN
https://www.forbes.com/sites/debraborchardt/2017/04/12/here-are-the-5-stocks-added-to-the-u-s-marijuana-index/?utm_source=yahoo&utm_medium=partner&utm_campaign=yahootix&partner=yahootix&yptr=yahoo#c7e1c8e52e71
The article below from the Boston Globe is about the explosive cannabis industry in Massachusetts.
It features ACAN and their MMCC project plus quotes CEO Tim Keogh.
ACAN is in a very strong position with their giant cannabis production plant south of Boston all approved and about to commence construction. Look at their website: $ACAN
AmeriCann.co
https://www.bostonglobe.com/magazine/2017/04/04/farmers-cannabis-could-mean-much-bigger-bucks-than-tomatoes/mVrlYgz3hQawDHVgQFvamL/story.html
CEO Tim Keogh, MMCC and ACAN are going to get an increasingly large amount of positive publicity throughout the year from the big Massachusetts project. IMO. $ACAN
See press release below.
AmeriCann to Present at The MicroCap Conference in New York City
Accesswire March 27, 2017
Presentation Scheduled for Tuesday, April 4 at 9:30am EST
DENVER, CO / ACCESSWIRE / March 27, 2017 / AmeriCann, Inc. (OTCQX: ACAN), an Ag-Tech company that is developing sustainable, state-of-the-art medical cannabis cultivation properties, announced today that Tim Keogh, Chief Executive Officer, will present at The MicroCap Conference in New York City on April 4, 2017.
The MicroCap Conference is an exclusive event for investors who specialize in MicroCap Companies to conduct one-on-one meetings with AmeriCann and other participating companies as well as view formal presentations. The conference will be held at The JW Marriott Essex House, 160 Central Park South, New York, NY 10019 at 9:30am ET on Tuesday, April 4, 2017.
AmeriCann is developing a 53-acre property in Massachusetts (acquired from Boston Beer Company (SAM-NYSE) for $4,475,000 in cash), as the Massachusetts Medical Cannabis Center (the "MMCC"). The MMCC is approved for 1 million square feet and is expected to be one of the largest and most technologically advanced cannabis cultivation facilities in the nation.
The regulated cannabis industry is one of the fastest growing industries in the country. The respected Wall Street firm of Cowen & Co recently released a research report projecting dramatic growth for the industry from the current $7 billion nationally to over $50 billion in ten years.
In November of 2016, Massachusetts, California, Maine, and Nevada voted to legalize recreational marijuana while Arkansas and North Dakota approved medical cannabis initiatives. Florida voters approved medical marijuana in a landslide with over 71% of the vote. With these election results, over 60% of the US Population now live in states where medical cannabis is now legal.
About The MicroCap Conference:
The MicroCap Conference is an exclusive event for investors who specialize in MicroCap Companies. It's an opportunity to be introduced to and speak with management at some of the most attractive small companies, to learn from our various expert panels, and to network with buyside analysts and other micro cap investors.
For those interested in attending, please contact Fred Rockwell at fred@microcapconf.com or visit www.microcapconf.com/conferences/new-york-2017/ for more information.
About AmeriCann:
AmeriCann (OTCQX: ACAN) is a publicly traded Ag-Tech company that is developing and sustainable, state-of-the-art medical cannabis cultivation properties. The Company has over 1,000,000 square feet of facilities in the planning and design stages of development. The Company has designed a proprietary line of cannabis infused products which will be branded and licensed to companies in regulated markets.
AmeriCann, Inc. is a Certified B Corp, an acknowledgment of the company's commitment to social and environmental ethics, transparency and accountability. AmeriCann became the first public cannabis company to earn this respected accreditation. More information about the Company is available at: www.americann.co or follow AmeriCann on Twitter @ACANinfo.
About Massachusetts Medical Cannabis Center:
The Massachusetts Medical Cannabis Center is approved for nearly 1,000,000 square feet of medical cannabis cultivation and processing in Freetown, Massachusetts. The state-of-the-art, sustainable, greenhouse project will consist of multiple planned phases for tenants in the Massachusetts medical marijuana market. AmeriCann's Cannopy System uniquely combines expertise from traditional horticulture, lean manufacturing, regulatory compliance and cannabis cultivation to create superior facilities and procedures.
The first phase of the project consists of 130,000 sq. ft. of cultivation and processing infrastructure. AmeriCann can expand the first phase to approximately 600,000 sq. ft., based on patient demand.
Great article on ACAN CEO Tim Keogh. $ACAN
March 24, 2017
https://itunes.apple.com/us/app/id320618758?mt=8
Massachusetts estimates $640 million legal cannabis revenue In 1918-9 and $1.3 billion 2019-20
Huge for ACAN mega cultivation project 47 miles from Boston.. $ACAN
Cannabis News Pro: see link below
http://www.bizjournals.com/boston/news/2017/03/20/state-taxes-on-recreational-marijuana-estimated-at.html
Very Nice story on the Massachusetts ACAN project and Company CEO Tim Keogh. See link below. $ACAN
http://www.heraldnews.com/news/20170319/massive-freetown-marijuana-facility-chance-for-one-man-to-return-to-his-roots
The institutional and larger family office money is coming into the cannabis space at a faster pace every week.
Massachusetts is red hot for cannabis development generally and the AmeriCann giant project south of Boston couldn't be in a better location.
Talk in Massachusetts of an April groundbreaking at MMCC if weather conditions cooperate.
ACAN has 1 million SF of prime greenhouse approved and ready to build--largest in the world if all built out-- what a great position for the company and their shareholders. This could be a legacy asset for ACAN for many years.
$ACAN
Sessions talked tough about how bad cannabis is in front of a police convention in Virginia yesterday but then told reporters afterward he'll respect the states rights.
More good news for the cannabis industry- Med and rec! Checkout the link below.
http://gfarma.news/breaking-news/jeff-sessions-suggests-crackdown-isnt-coming-legal-weed/
ACAN Massachusetts project named top 5 new cannabis facilities to watch in 2017. By the time ACAN has the groundbreaking ceremony in Freetown in mid April this could already be a very high priced stock! Massachusetts is becoming the hub for cannabis on the east coast.
http://www.cannabisbusinesstimes.com/article/cannabis-facilities-to-watch-in-2017/
ACAN is the big winner from the uncertainty about the new administration regarding
cannabis legality.
Their Massachusetts project
is based on and works great if the industry is only Medical
cannabis. If adult use stays in place it's only a bonus.
There is major capital coming into the cannabis sector and now they're all looking for investments in the medical side.
ACAN has their giant medical facility (MMCC) shovel ready in the best market for development in the industry.
Looking like a very exciting 2017 for ACAN shareholders.
ACAN is one of the few public cannabis companies that could prosper if there is medical cannabis only. Their giant Massachusetts project is all based on medical and is highly profitable with just that. Medical in Massachusetts without recreational would be a $800 million a year industry and require 3 million SF of new greenhouses. ACAN wins either way. $ACAN
http://mjbizdaily.com/chart-rec-mj-markets-in-washington-colorado-still-growing/
The industry continues to boom and no market is booming more than Massachusetts. ACAN's 1 million SF cannabis business park near Boston is going to make them a major player in the national cannabis industry by mid year. CEO Tim Keogh is on the panel about the cannabis industry in Massachusetts at Boston University this coming Wednesday at 5:30.
Anyone in the Boston area should attend. Google Boston U. "Beyond Stigma" for details. $ACAN
Anyone who is serious about knowing more about AmeriCann (ACAN) and their plans, business model and potential should take the time to read the lengthy but exciting report from CNA Finance available below.
This ACAN company management team has done a lot of things very right and the smart money is about to figure it out.
Also:
ACAN was just added to prestigious LD Micro Stock Index.
Just filed 10-Q ahead of time showing almost $1 million in cash for operations.
CEO Tim Keogh selected as key panelist for major cannabis forum on the future of legal Cannabis in Massachusetts at Boston U Business School in late February.
http://cnafinance.com/americann-inc-acan-leading-the-large-scale-cannabis-cultivation-trend-in-the-rapidly-growing-cannabis-industry/13689
Tim Keogh the CEO of Americann (ACAN) is the featured speaker on Wednesday, February 8 at the big Massachusetts cannabis commercial real estate forum from 8 AM to noon in Boston.(Flyer below)
The event is so popular the sponsors had to expand the size of the room twice and it looks like close to 300 will attend.
Tim will also be available to meet in person so anyone in the Boston area that is a shareholder or prospective shareholder might want to attend (may be sold out so confirm availability if interested) Could be a chance to meet Tim and hear first hand about the ACAN giant MMCC high tech cannabis production center in Massachusetts.
Massachusetts is fast becoming the epicenter for cannabis in the northeast and ACAN is at the forefront.
$ACAN... next stop $5.
I'm thinking ACAN will see $5 this week, setting a new HIGH (Pun Intended)
$ACAN
I think we see a new high today. $ACAN
This is a new report from Oracle-a respected cannabis research newsletter. Very positive and worth reading. More financial services are starting to write positively about AmeriCann and the interest is broadening.
http://oracledispatch.com/2017/01/29/americann-inc-otcmktsacan-takes-stage/
AmeriCann Morningstar Jan 24 2017.pdf
?
The highly regarded research firm Morningstar has begun coverage of AmeriCann (ACAN) with a three star rating- meaning fairly valued.
(See attached)
They say in the report:
"AmeriCann Inc., develops and supports medical cannabis cultivation and processing facilities. The company brings professionalism and traditional horticulture and proven business practices to the medical cannabis industry."
As far as I can tell this Morningstar profile is not a common thing for a small cap cannabis stock.
Look for more research firms to follow the stock as it is moving higher on expanded trading volume.
And a move above $5 would be significant as it allows more of the larger broker/dealers to become involved in the ACAN stock.
The main reason ACAN is continuing to trade higher on expanded volume is that more serious investors are looking at the whole industry and when they do they realize ACAN is the real deal they have been looking for.
Good management with skin in the game, business plan that offers potential for real cash flow and scalability and the biggest and most exciting project in the industry (MMCC) ready to build in the hottest cannabis state in the nation-Massachusetts.(California is the hottest state long term but it will be 2019-20 before it really kicks in-Massachusetts will have big growth in 2017-18)
If ACAN trades up to $10 as some are predicting this is still only a $200 million market capitalization.
There are probably 50 cannabis stocks (counting Canada) trading over $200 million and I'd bet not many of them offer the potential of ACAN.
That are in the right place at the right time with the right business model.
$4 around the corner. IMO.. nice run today ACAN.
ACAN is still only valued in the market at under $60 million. Dozens and dozens of Cannabis stocks with almost no operations trade at a $60 million+ valuation just because they have cannabis in the name.
Seven Canadian growers now have market values averaging over $400 million (US) and some over $1 billion Also 25 US cannabis stocks now trade over $100 million valuations.
None of these has the upside potential of ACAN. They have cash in the bank, other good assets, their own Solanna infused product line, and the management team has more cannabis industry experience and knowledge than almost any others.
Management is knowledgeable and have over $5 million of their own cash invested in the company--a rarity in the cannabis space.
When they break ground on the MMCC project the ACAN stock will very likely be way higher than it is today- and the schedule is for March.
The attached news story about ACAN's giant Massachusetts Medical Cannabis Center is one and of many that are being written and more are sure to come.
If they have a groundbreaking in March as is being planned this is going to really big story. The impact-both financially and from a PR prospective--on ACAN from this project is going to be major (if they do get final financing and break ground).
https://www.networknewswire.com/networknewsbreaks/networknewsbreaks-americann-inc-acan-building-one-nations-largest-mmj-facilities/
Someone asked how "legit" ACAN is in a recent posting.
A good question and here are some answers that I have been able to assemble from company filings and public releases.
I am not unbiased as I have been a shareholder since the first round of financing at $.75 in 2014 and retain a long term position in the ACAN stock. (I also own GW Pharma (GWPH,) and two Canadian producers- Canopy Growth ( CGC-TO) and Emblem (EMC-V).
Here's my personal analysis on AmeriCann:
....ACAN is one of the earliest public cannabis companies-it began operations in late 2013 with trading in 2014.
Colorado based- in the "Silicon Valley" of the cannabis industry- which gives them significant industry knowledge and important "early mover" advantages.
ACAN CEO Tim Keogh headed a group that was awarded one of the first medical cannabis licenses in highly competitive Massachusetts in 2014 shortly after becoming the ACAN CEO. This gave him early knowledge of and access to the Massachusetts market.
Mr. Keogh is widely regarded as one of the most respected and knowledgeable executives by cannabis industry insiders. (From my conversations with people in the industry)
The Founder of AmeriCann is also largest shareholder, CFO and a director. He is a venture capitalist who also Co-founded SYRG which went from a pure startup to $1.7 Billion value on NYSE.
Founder and his family have invested over $7 million cash in ACAN to launch and build the business model- a rare event in public or private cannabis companies.
ACAN has done Four $1 million+ cannabis real estate deals in three states-Colorado, Illinois and Massachusetts, (which is by far the biggest the most impactive and the company "Flagship " project.)
Listed OTCQX- highest level of OTC-one of only a handful of cannabis companies to gain this listing.
Certified B Corp- awarded for demonstration of corporate, environmental and social responsibility. Only cannabis co to achieve this designation.
Company invested over two years and $1.5 million to get MMCC planned and fully approved as the largest most advanced and energy efficient cannabis production plant in the world- is fully approved for 1 million SF - 25 football sized greenhouses at buildout.
Closed on $4.5 million cash land purchase from Boston Beer (SAM--NYSE) in September '16 on 52 acre property 47 miles from Boston for development of their Massachusetts Medical Cannabis Center (MMCC)
ACAN management decision to concentrate their time and resources on designing and gaining all approvals for their mega MMCC cannabis business park looks very smart as Massachusetts voters approved recreational cannabis in November.
Experts now project $1 billion annual cannabis market in Massachusetts by 2020- which will require up to 4 million SF to grow and cultivation capacity is very limited to date.
First phase of 160,000 SF greenhouse at MMCC pre leased to Massachusetts Medical Cannabis licensee and in final working drawings and preparing for bids.
Campanelli- a large Boston based construction company has been an invaluable design partner and was awarded the construction contract for MMCC. ACAN and Campanelli are planning on future projects together.
Groundbreaking on MMCC project scheduled March '17 with first revenue to ACAN expected Q4 '17. (Final financing not yet in place as of latest filings.)
ACAN Completed a $2 million equity raise in Q 4 '16 with broker/dealers.
Clean balance sheet with about $1,000,000 cash for operations. Only 20 million shares. No cheap options
or conv debt. Management owns about 70%.
Preparing for expansion into numerous additional states using MMCC model.
Company is developing its own SOLANNA line of advanced smokeless cannabis infused products-including lotions and creams, capsules, dermal patches, sprays and drinks-to be developed at their MMCC project. (See website)
ACAN stock up 500%+in 2016 on strong increase in daily trading volume as more Investors learn about ACAN and MMCC upside possibles.
Even with stock price increases ACAN has a Market valuation of only $60 million with many cannabis stocks trading at $200 million+- which would translate to a stock price of $10 per share.
Do your own research, read their releases and public filings and buyer beware as this is a highly risky industry and the company business plan will require more capital.
But I like what these guys have accomplished, their patient long term "big picture" approach to the industry and the exciting potential this company offers.
AmeriCann.co
$ACAN on Twitter
This video explains more detail about the Massachusetts cannabis market potential.
Very positive for ACAN.
The word is getting out that ACAN is about to become an important company in the fast growing Massachusetts cannabis market.
Attached is another nice mention in a research piece.
http://www.cannabisstocktrades.com/buzz/
New Frontier is a highly respected cannabis research firm and they just came out with a $1 billion annual Massachusetts MJ market prediction.
This is very positive for ACAN and their mega 1 million Square Foot cannabis production and processing plant south of Boston.
This $1 billion annually will require over 5 million SF of cannabis cultivation facilities in Massachusetts by 3 years and the state only has 300,000.
ACAN's way ahead of everyone else here and the shareholders will benefit from it for years to come.
http://m.marketwired.com/press-release/new-report-massachusetts-marijuana-sales-to-top-1-billion-by-2020-2184806.htm
AmeriCann.co
http://m.marketwired.com/press-release/new-report-massachusetts-marijuana-sales-to-top-1-billion-by-2020-2184806.htm
Massachusetts has a total of under 300,000 SF of cannabis cultivation in place and will require at least 3 million SF by 2019( two years) for medical MJ. Full legalization is expected to create a massive $1 billion market here by 2021.
ACAN will very likely get their financing for this project and break ground in just over two months in mid March just like planned. When they do the publicity and media coverage will be everywhere.
The real question is what will the ACAN stock be trading for if this does happen?
The answer is the stock will be many times higher than today and even skeptics know that is true.
Love this company, be neutral or hate it, but at least take the time to study and understand it. The upside potential here is really exciting.
All the talk about whether ACAN will be able to get the financing to build their Massachusetts mega cannabis plant is missing the point.
First, they are not in the least concerned about getting the construction financing to build the first greenhouses and anyone that understands this company and this Massachusetts market knows that.
There is now lots of capital available for "real" cannabis deals- and a 30,000 SF pre leased cultivation and processing facility in Mass that can produce 4,000 pounds of medical cannabis a year is as real as it gets.
ACAN has the biggest and most exciting project in the cannabis industry in the hottest state for new cannabis development, period.
They spent $1.5 million and two years getting this giant project approved plus closed on the land for $4.6 million before Massachusetts voted to legalize.
They were 100% right in making a major bet on the Massachusetts MJ market and its about to pay off big time. They'll be developing this 1 million SF non stop for the next two years and every new SF of greenhouse on the site will increase their cash flow-which will be substantial.